DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Nowotny B, Thomas D, Schwers S. et al.
First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men.
J Thromb Haemost 2022;
20 (07) 1684-1695
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.